Cryofab, Inc. is a cryogenic equipment manufacturing company that specializes in producing products for the safe storage, transportation, and transfer of liquid gases. The company offers custom and standard fabrications used in various industries including biotechnology, pharmaceutical, superconductivity, semiconductor, and medical fields. With offerings such as standard containers, transfer lines for various liquified gases, and a wide range of cryogenic containers like liquid nitrogen dewars and liquid helium dewars, Cryofab caters to a diverse set of applications. Moreover, their in-house engineering capabilities enable them to assist in product development for OEM or private label fabrication.
Founded in 1971, Cryofab has established itself as a medium-sized, small business and is known for its innovative products and superior service. The company is headquartered in the United States. As it continues to grow and develop, it presents an opportunity for venture capitalists to invest in a company with a strong track record and a focus on meeting the evolving needs of various industries. With its capabilities of customizing products to meet technical standards such as ASME, DOT, and ANSI, Cryofab offers a promising investment prospect for venture capitalists seeking to back companies at the forefront of cryogenic equipment innovation and manufacturing. For further information, interested investors can reach out to [email protected].